Acer Therapeutics Inc. Quarterly Goodwill in USD from Q4 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Acer Therapeutics Inc. quarterly Goodwill history and growth rate from Q4 2016 to Q3 2023.
  • Acer Therapeutics Inc. Goodwill for the quarter ending September 30, 2023 was $7.65M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $7.65M $0 0% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $7.65M $0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.65M $0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $7.65M $0 0% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 $7.65M $0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $7.65M $0 0% Jun 30, 2022 10-Q/A 2022-11-14
Q1 2022 $7.65M $0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $7.65M $0 0% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $7.65M $0 0% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 $7.65M $0 0% Jun 30, 2021 10-Q/A 2021-11-19
Q1 2021 $7.65M $0 0% Mar 31, 2021 10-Q/A 2021-11-19
Q4 2020 $7.65M $0 0% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $7.65M $0 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $7.65M $0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $7.65M $0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $7.65M $0 0% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $7.65M $0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $7.65M $0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $7.65M $0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $7.65M $0 0% Dec 31, 2018 10-K 2020-03-18
Q3 2018 $7.65M +$1.00 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $7.65M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $7.65M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $7.65M +$7.37M +2708% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $7.65M Sep 30, 2017 10-Q 2017-11-13
Q4 2016 $272K Dec 31, 2016 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.